494 related articles for article (PubMed ID: 28056976)
1. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
2. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
3. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.
Gaj P; Habior A; Mikula M; Ostrowski J
BMC Med Genet; 2008 Aug; 9():81. PubMed ID: 18715515
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association analysis in primary sclerosing cholangitis.
Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
[TBL] [Abstract][Full Text] [Related]
7. Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms.
Sebode M; Peiseler M; Franke B; Schwinge D; Schoknecht T; Wortmann F; Quaas A; Petersen BS; Ellinghaus E; Baron U; Olek S; Wiegard C; Weiler-Normann C; Lohse AW; Herkel J; Schramm C
J Hepatol; 2014 May; 60(5):1010-6. PubMed ID: 24412607
[TBL] [Abstract][Full Text] [Related]
8. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
Srivastava B; Mells GF; Cordell HJ; Muriithi A; Brown M; Ellinghaus E; Franke A; ; Karlsen TH; Sandford RN; Alexander GJ; Chapman RW; Rushbrook SM; Melum E
Scand J Gastroenterol; 2012 Jul; 47(7):820-6. PubMed ID: 22554193
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
10. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
[TBL] [Abstract][Full Text] [Related]
11. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
Webb GJ; Hirschfield GM
J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
[TBL] [Abstract][Full Text] [Related]
12. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
[TBL] [Abstract][Full Text] [Related]
14. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
15. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
Dyson JK; Blain A; Foster Shirley MD; Hudson M; Rushton S; Jeffreys Jones DE
JHEP Rep; 2021 Feb; 3(1):100202. PubMed ID: 33474546
[TBL] [Abstract][Full Text] [Related]
16. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
Liu JZ; Hov JR; Folseraas T; Ellinghaus E; Rushbrook SM; Doncheva NT; Andreassen OA; Weersma RK; Weismüller TJ; Eksteen B; Invernizzi P; Hirschfield GM; Gotthardt DN; Pares A; Ellinghaus D; Shah T; Juran BD; Milkiewicz P; Rust C; Schramm C; Müller T; Srivastava B; Dalekos G; Nöthen MM; Herms S; Winkelmann J; Mitrovic M; Braun F; Ponsioen CY; Croucher PJ; Sterneck M; Teufel A; Mason AL; Saarela J; Leppa V; Dorfman R; Alvaro D; Floreani A; Onengut-Gumuscu S; Rich SS; Thompson WK; Schork AJ; Næss S; Thomsen I; Mayr G; König IR; Hveem K; Cleynen I; Gutierrez-Achury J; Ricaño-Ponce I; van Heel D; Björnsson E; Sandford RN; Durie PR; Melum E; Vatn MH; Silverberg MS; Duerr RH; Padyukov L; Brand S; Sans M; Annese V; Achkar JP; Boberg KM; Marschall HU; Chazouillères O; Bowlus CL; Wijmenga C; Schrumpf E; Vermeire S; Albrecht M; ; Rioux JD; Alexander G; Bergquist A; Cho J; Schreiber S; Manns MP; Färkkilä M; Dale AM; Chapman RW; Lazaridis KN; ; Franke A; Anderson CA; Karlsen TH;
Nat Genet; 2013 Jun; 45(6):670-5. PubMed ID: 23603763
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
18. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis.
Greverath LM; Leicht E; Wald de Chamorro N; Wilde AB; Steinhagen LM; Lieb C; Schmelzle M; Chopra S; Shibolet O; Fischer J; Berg T; Tacke F; Müller T
Hepatol Res; 2020 Mar; 50(3):321-329. PubMed ID: 31747477
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]